Miller Matthew P 4/A
4/A · Oncology Institute, Inc. · Filed Nov 22, 2022
Insider Transaction Report
Form 4/AAmended
Miller Matthew P
Chief Operating Officer
Transactions
- Sale
Common Stock
2022-11-15$2.03/sh−577$1,170→ 78,034 total
Footnotes (2)
- [F1]This Form 4/A amends and restates the reporting persons Form 4 originally filed on November 17, 2022 in the entirety. This Form 4/A is being filed to correct the reporting persons original Form 4 from Code D to Code S. The sales reported in the Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.022 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.